Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn... ( Introducing proprietary Derma prod...)

Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings

Date:4/23/2008

Introducing proprietary Derma product to 32,000+ healthcare providers

PRINCETON, N.J., April 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has signed a new multi-year supply agreement with one of the nation's largest group purchasing organizations, MedAssets Supply Chain Systems, a MedAssets company (Nasdaq: MDAS). The 3-year agreement, with an effective date of June 1, 2008, will help to introduce MEDIHONEY(TM) Wound & Burn Dressing with Active Leptospermum Honey to the organization's growing customer base, and will provide these customers with a group discounted rate. Currently, MedAssets serves more than 125 health systems, 2,500 hospitals and 30,000 non-acute care healthcare providers. On an annual basis, MedAssets manages on behalf of its customers, an excess of $15 billion in supplies and services.

This supply agreement for specialty advanced wound care products features Derma Sciences' MEDIHONEY, line of dressings with Active Leptospermum Honey for managing a wide variety of wounds and burns. In July, the FDA gave its initial clearance of MEDIHONEY, and the product was launched last fall. Since then, another clearance for a line extension has been granted and a third is pending. Sales have rapidly increased, and over 20 clinical abstracts on the use of the product have been accepted at various wound conferences in 2008.

Marta V. Beile RN, a director of clinical supply chain for MedAssets' materials management division, decided it would be highly beneficial for MedAssets customers to carve out a "specialty" products agreement for this exciting new product. Beile stated, "It makes sense to provide our wound care cli
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Galderma Completes Acquisition of CollaGenex
2. AGI Dermatics Closes $5 Million Investment Round
3. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
4. Derma Sciences Reports Fourth Quarter Year-End Results for 2007
5. Derma Sciences MEDIHONEY(TM) Profiled in Several Television News Health Reports
6. Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA
7. Biologics, Derma Fillers are Key to Dermatological Drug Market Growth
8. Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
9. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
10. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
11. Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications

Post Your Comments:

Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn...( Introducing proprietary Derma prod...)